Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Korean Air anticipates uncertainties in the business environment this year due to shifts in the global political landscape, ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...

Greetings and welcome to the Hillenbrand first quarter and full year 2025 earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal ...

Yu Yi, technology lead at Accenture China, said that as companies strive to stay ahead and adapt to fast-changing markets, ...

Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven ...

A group of 17 Republican state attorneys general alleged that top U.S. asset managers, including BlackRock and State Street , ...

A delay to US tariffs on goods from Mexico and Canada has done little to suggest Trump will change his course on trade levies ...

Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction, ...

Companies across the country are bleeding cash as they struggle with overcapacity and weak spending in a slumping economy, ...